Kenneth I. Kaitin, PhD

Kenneth I. Kaitin, PhD, is director of the Tufts Center for the Study of Drug Development at Tufts University.


Beyond the Blockbuster

For decades, blockbuster product development has driven the pharmaceutical industry. Under that model, a handful of products-and, in some cases, a single product-produce the lion's share of revenue and dictate a company's strategic direction. As companies get larger, they rely more and more on blockbusters to sustain their growth. The high cost of developing major, successful drugs only reinforces the need to focus on blockbusters. It's a vicious cycle that remains firmly in place for most Big Pharma.